Tag: PROMISE II

LimFlow raises US$40 millions in Series D financing

LimFlow recently announced it has closed a US$40 million (€36 million) oversubscribed Series D financing round. A press release reports that new investors Longitude...

PROMISE II U.S. pivotal trial of device designed for ‘no-option’ CLTI...

Enrolment has been completed in the PROMISE II pivotal trial of the LimFlow deep vein arterialisation system designed to prevent amputations in so-called "no-option"...

LimFlow receives Japan PMDA approval for clinical study of minimally-invasive technology

LimFlow announced today that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has approved its Clinical Trial Notification (CTN) for the Japanese cohort of...